FTC to study authorized generics
The Federal Trade Commission plans to investigate the likely short- and long-term competitive effects of authorized generic versions of brand drugs. FTC staffers have been authorized to subpoena about 80 drug companies, 10 authorized generic companies, and 100 independent generic manufacturers.
FTC to study authorized generics
The Federal Trade Commission plans to investigate the likely short- and long-term competitive effects of authorized generic versions of brand drugs. FTC staffers have been authorized to subpoena about 80 drug companies, 10 authorized generic companies, and 100 independent generic manufacturers. Public comments to be used to refine the research will be accepted until June 5. A final report is expected sometime next year.
To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.
